Fig. 4.1

Fig. 4.1

Metabolic pathways of sulfasalazine in humans

From Das & Dubin (1976), NTP (1997a). With kind permission from Springer Science and Business Media.

From: 4, Mechanistic and Other Relevant Data

Cover of Some Drugs and Herbal Products
Some Drugs and Herbal Products.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 108.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
© International Agency for Research on Cancer, 2016. For more information contact publications@iarc.fr.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.